Evidence map›Paper›PMID 28482013›Full record

ArticleThe international journal of neuropsychopharmacology2017

Hydrogen Sulfide Inhibits Chronic Unpredictable Mild Stress-Induced Depressive-Like Behavior by Upregulation of Sirt-1: Involvement in Suppression of Hippocampal Endoplasmic Reticulum Stress.

Shu-Yun Liu, Dan Li, Hai-Ying Zeng, Li-Yuan Kan, Wei Zou, Ping Zhang, Hong-Feng Gu, Xiao-Qing Tang

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Age-dependent effects of HFrontiers in psychiatry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. HJournal of clinical medicine · 2021
    Article
  11. HNeurochemical research · 2021
    Article
  12. Article
  13. SIRT1 Mediates HNeurochemical research · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shu-Yun LiuDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Dan LiDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Hai-Ying ZengDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Li-Yuan KanDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Wei ZouDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Ping ZhangDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Hong-Feng GuDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Xiao-Qing TangDepartment of Neurology, Affiliated Center Hospital of Shenzhen Longhua New District, Guangdong Medical University, Shenzhen, Guangdong, P. R. China; Institute of Neuroscience, Medical College, University of South China, Hengyang, Hunan, P. R. China; Department of Neurology, Nanhua Affiliated Hospital, University of South China, Hengyang, Hunan, P. R. China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, PR China.
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hydrogen sulfide (H2S) is a crucial signaling molecule with a wide range of physiological functions. Previously, we confirmed that stress-induced depression is accompanied with disturbance of H2S generation in hippocampus. The present work attempted to investigate the inhibitory effect of H2S on chronic unpredictable mild stress-induced depressive-like behaviors and the underlying mechanism. Methods: We established the rat model of chronic unpredictable mild stress to simulate depression. Open field test, forced swim test, and tail suspension test were used to assess depressive-like behaviors. The expression of Sirt-1 and three marked proteins related to endoplasmic reticulum stress (GRP-78, CHOP, and cleaved caspase-12) were detected by western blot. Results: We found that chronic unpredictable mild stress-exposed rats exhibit depression-like behavior responses, including significantly increased immobility time in the forced swim test and tail suspension test, and decreased climbing time and swimming time in the forced swim test. In parallel, chronic unpredictable mild stress-exposed rats showed elevated levels of hippocampal endoplasmic reticulum stress and reduced levels of Sirt-1. However, NaHS (a donor of H2S) not only alleviated chronic unpredictable mild stress-induced depressive-like behaviors and hippocampal endoplasmic reticulum stress, but it also increased the expression of hippocampal Sirt-1 in chronic unpredictable mild stress-exposed rats. Furthermore, Sirtinol, an inhibitor of Sirt-1, reversed the protective effects of H2S against chronic unpredictable mild stress-induced depression-like behaviors and hippocampal endoplasmic reticulum stress. Conclusion: These results demonstrated that H2S has an antidepressant potential, and the underlying mechanism is involved in the inhibition of hippocampal endoplasmic reticulum stress by upregulation of Sirt-1 in hippocampus. These findings identify H2S as a novel therapeutic target for depression.

Indexed as

AnimalsAntidepressive AgentsCaspase 12DepressionDisease Models, AnimalDose-Response Relationship, DrugEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressExploratory BehaviorHeat-Shock ProteinsHindlimb SuspensionHippocampusHydrogen SulfideMaleRatsRats, WistarAntidepressive AgentsCaspase 12Ddit3 protein, ratEndoplasmic Reticulum Chaperone BiPGRP78 protein, ratHeat-Shock ProteinsHydrogen SulfideSirt1 protein, ratSirtuin 1Transcription Factor CHOPchronic unpredictable mild stressdepressionendoplasmic reticulum stresshydrogen sulfidesilent mating type information regulation 2 homolog 1

Identifiers

PMID28482013
PMCPMC5737807
OpenAlexW2611106583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.